Table 2 Clinical Study Characteristics
Study | Type | n | Initial AVN class | AVN etiology (# of hips) | Treatment protocol |
|---|---|---|---|---|---|
Hernigou et al. [35] | Case series | 534 | Ficat 1-2 | steroid (101), ethanol (150), sickle cell (166), not specified (117) | Concentrated BMMNC |
Wang et al. [9] | Case series | 50 | ARCO 1-2 | steroid (25), ethanol (19), idiopathic (6) | Concentrated BMMNC |
Gangji et al. [2] | nRCT | 24 | ARCO 1-2 | steroid (20), ethanol (2), idiopathic (2) | Concentrated BMMNC |
Sen et al. [14] | RCT | 51 | ARCO 1-2 | trauma (17), steroid (20), ethanol 8), idiopathic (2), pregnancy (2), Cushings (2) | Concentrated BMMNC |
Zhao et al. [8] | RCT | 97 | ARCO 1C-2C | trauma (20), steroid (24), ethanol (19), Caisson (11), idiopathic (30) (some patients had more than one etiology) | Cultured BMMNC |